Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATP: GA and Methylprednisolone after Natalizumab in MS
NCT01710228Phase 2Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2013
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in multiple sclerosis (MS), sponsored by UT Southwestern Medical Center. Planned start Jul 2013; status: withdrawn.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01710228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710228.